Latest Affymetrix (AFFX) Headlines Global Bioin
Post# of 33
Posted On: 03/12/2014 5:34:43 PM
Latest Affymetrix (AFFX) Headlines
Global Bioinformatics Market 2014-2018 with Accelrys, Affymetrix, Agilent, CLCbio A/S & Illumina Dominating
M2 - Thu Mar 06, 10:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/r5lxv6/global) has announced the addition of the "Global Bioinformatics Market 2014-2018 with Accelrys, Affymetrix, Agilent, CLCbio A/S & Illumina Dominating" report to their offering. The Global Bioinformatics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC region; it also covers the Global Bioinformatics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. As a result of declining budgets for R&D, biotechnology companies and other organizations are seeking ways to increase efficiency by outsourcing bioinformatics to effectively support their R&D activities at less cost. Also, outsourcing may be an increasingly viable option for research organizations which lack the requisite computational infrastructure and informatics expertise for bioinformatics tools in house. Outsourcing the services to a third-party vendor can allow an organization to refocus on key projects that contribute to increasing the effectiveness of its R&D and shorten development-to-launch timelines. One of the major drivers in this market is the decreasing cost of genetic sequencing. This reduction in cost is a result of the development of tools and technologies as well as the improvements in processes made by genomics researchers. The report states that one of the major challenges in the market is the growing complexity in using bioinformatics tools and the consequent need for proper training and guidance to use these tools properly and efficiently. The key vendors dominating this market space are: - Accelrys Inc. - Affymetrix Inc. - Agilent Technologies Inc. - CLCbio A/S - Illumina Inc. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Products and Services 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/r5lxv6/global
AKESOgen and the VA Million Veteran Program to Collaborate on Genotyping 105,000 Veterans
Business Wire - Wed Mar 05, 9:00AM CST
AKESOgen announced today that it has been awarded a $7.5M contract by the U.S. Department of Veterans Affairs (VA) for genotyping samples from U.S. veterans as part of the Million Veteran Program (MVP). This award covers the genotyping of 105,000 veterans in the first year of a five-year contract.
Global Proteomics Market 2012-2016: One of the Main Drivers in This Market Is the Increasing Demand for Personalized Medicines
M2 - Fri Feb 28, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/dn2hwq/global_proteomics) has announced the addition of the "Global Proteomics Market 2012-2016" report to their offering. The analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp. The other vendors mentioned in the report are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., and Bruker Daltonics Inc. Commenting on the report, an analyst from the Healthcare team said: ''One of the recent trends being witnessed in the Global Proteomics market is the growing popularity of proteomic analysis as compared to genomic analysis. Both genomics and proteomics find application in drug discovery, disease diagnosis, and drug development. Genomics is the study of the genes or DNA of an organism. Proteomics, which was introduced after genomics, has become more popular because it offers more benefits than genomics. For instance, proteomic analysis is faster and more effective in terms of data analysis than genomic analysis. Thus, there is a considerable shift from genomics to proteomics for disease diagnosis and drug development. This trend augers well for the growth of the Global Proteomics market during the forecast period.'' For more information visit http://www.researchandmarkets.com/research/dn...proteomics About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
3 Stocks Under $10 Making Big Moves
at The Street - Wed Feb 26, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Global Life Science and Chemical Instrumentation Market 2012-2016: Market Size and CAGR
M2 - Tue Feb 25, 12:15PM CST
Research and Markets (http://www.researchandmarkets.com/research/25grxg/global_life) has announced the addition of the "Global Life Science and Chemical Instrumentation Market 2012-2016" report to their offering. The analysts forecast the Global Life Science and Chemical Instrumentation market to grow at a CAGR of 8.64 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid technological developments in the Diagnostics industry. The Global Life Science and Chemical Instrumentation market has also been witnessing an increasing number of outsourcing activities. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Roche Holding Ltd., Thermo Fischer Scientific Inc., Life Technologies Corp., and Agilent Technologies Inc. The other vendors mentioned in the report are Danaher Corp., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Affymetrix Inc., GE Healthcare Ltd., Perkin Elmer Inc., Siemens Healthcare, Abbott Laboratories, Hitachi High-technologies Corp., RainDance Technologies Inc., Tecan Group Ltd., Eppendorf AG, Oxford Nanopore Technologies Ltd., and Genia Corp. Commenting on the report, an analyst from Healthcare team said: ''Increasing outsourcing activities is one of the emerging trends in the Global Life Science and Chemical Instrumentation market. Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. This is because outsourcing reduces manufacturing and distribution costs, ensures quality of services, and reduces lead time. In addition, it helps the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. On this front, the Asian and Latin American countries are experiencing high growth. For instance, one of the most preferred locations for outsourcing is Singapore because it is known for its strong intellectual property laws, excellent supply chain, and wide logistics connectivity. Moreover, it is considered a major base for setting up biotechnology and pharmaceutical manufacturing companies because of favorable tax incentives.'' For more information visit http://www.researchandmarkets.com/research/25...lobal_life About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Myriad Genetics Unveils Prolaris Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 1:50PM CST
Shares of Myriad Genetics surged 11.4% at yesterday's market close following the company's recent release of positive data on its Prolaris test.
The Bioinformatics Market to Expand at a CAGR of Around 18.5% during 2013-2017
M2 - Tue Feb 11, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/cnkvh4/global) has announced the addition of the "Global Bioinformatics Market Forecast to 2017" report to their offering. Bioinformatics has become one of the liveliest markets in the present scenario and is at the forefront of biotech revolution. The increasing application of genomics in biotech and pharmaceutical research & development has created a huge commercial market for bioinformatics worldwide. Over the past decade, the bioinformatics market has significantly evolved across the globe on the back of rising genomics industry. In the latest research study, Global Bioinformatics Market Forecast to 2017, analysts identified that the global bioinformatics market reached the mark of around US$ 3.2 Billion in 2012. In future, the bioinformatics market will expand at a CAGR of around 18.5% during 2013-2017 as the declining cost of human genome sequencing and increasing public & private sector investments will give a significant boost to the industry. Our report also covers the key trends and drivers like rising potential of bioinformatics outsourcing industry, cloud computing in bioinformatics, increasing bioinformatics R&D efforts by players etc. In its report, we have studied the bioinformatics market performance by segments, by applications and by regions. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. In 2012, the tools and database market including specialized and generalized databases was the biggest segment of the global bioinformatics industry. In addition, the report analyzes the wide application of bioinformatics in genomics, proteomics and pharmacogenomics. Regional analysis includes the market's categorization into Europe, Asia-pacific and North America, the leading regions in 2012. Further, country level analysis discusses bioinformatics market in major countries like US, Germany, South Korea, UK, Japan etc., to understand their individual market growth and future directions. In addition, the market has witnessed the launches of key bioinformatics products and services in various areas, and we have evaluated these on the basis of the companies and countries, in its report. Companies Mentioned: - 3rd Millennium Inc - Accelrys, Inc. - Affymetrix, Inc. - Biodiscovery, Inc - CLC Bio A/S - Compugen Ltd. - Geneva Bioinformatics (Genebio) SA - Genologics Life Sciences Software, Inc - Kinexus Bioinformatics Corporation - Life Technologies Corporation For more information visit http://www.researchandmarkets.com/research/cnkvh4/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Affymetrix Slips to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 2:30PM CST
On Feb 7, Zacks Investment Research downgraded Affymetrix to a Zacks Rank #3 (Hold).
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Feb 08, 7:00AM CST
What kind of week do you suppose Peyton Manning, star quarterback of the Denver Broncos, had this week? After the horrible Super Bowl loss to the Seattle Seahawks, it probably wasn't too great for Manning and the rest of the Denver team. ...
Covance Tops Earnings & Revs, Initiates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 12:20PM CST
Covance reported adjusted earnings per share (EPS) of 87 cents in the fourth quarter of 2013.
Affymetrix (AFFX) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 8:37AM CST
Affymetrix (AFFX) Enters Oversold Territory
TrendingWallStreet.com Conducts Research on AFFX, WUBA, PLPL, and SFLY
ACCESSWIRE - Thu Feb 06, 11:18PM CST
Whether it's a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Nasdaq stocks posting largest percentage decreases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Acquisition and Earnings Beat Lift Myriad Shares - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 4:00PM CST
Myriad shares rise following twin announcements made by the company.
Why Affymetrix, Inc. Shares Dropped
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 06, 12:14PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Affymetrix , a life science tools and...
Affymetrix Sees Turnaround Quarter but Earnings Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 8:50AM CST
The turnaround result was caused by increase in revenues and decrease in costs and expenses during the quarter.
Myriad Genetics Inc. (MYGN) Soars: Stock Adds 15.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 8:21AM CST
Myriad Genetics Inc. (MYGN) was a big mover last session, as the company saw its shares rise by over 15% on the day.
Strength Seen in Pain Therapeutics Inc. (PTIE) Stock Surges 24% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 7:44AM CST
Pain Therapeutics Inc. was a big mover last session, as the company saw its shares surge over 21% on the day.
Global Bioinformatics Market 2014-2018 with Accelrys, Affymetrix, Agilent, CLCbio A/S & Illumina Dominating
M2 - Thu Mar 06, 10:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/r5lxv6/global) has announced the addition of the "Global Bioinformatics Market 2014-2018 with Accelrys, Affymetrix, Agilent, CLCbio A/S & Illumina Dominating" report to their offering. The Global Bioinformatics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC region; it also covers the Global Bioinformatics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. As a result of declining budgets for R&D, biotechnology companies and other organizations are seeking ways to increase efficiency by outsourcing bioinformatics to effectively support their R&D activities at less cost. Also, outsourcing may be an increasingly viable option for research organizations which lack the requisite computational infrastructure and informatics expertise for bioinformatics tools in house. Outsourcing the services to a third-party vendor can allow an organization to refocus on key projects that contribute to increasing the effectiveness of its R&D and shorten development-to-launch timelines. One of the major drivers in this market is the decreasing cost of genetic sequencing. This reduction in cost is a result of the development of tools and technologies as well as the improvements in processes made by genomics researchers. The report states that one of the major challenges in the market is the growing complexity in using bioinformatics tools and the consequent need for proper training and guidance to use these tools properly and efficiently. The key vendors dominating this market space are: - Accelrys Inc. - Affymetrix Inc. - Agilent Technologies Inc. - CLCbio A/S - Illumina Inc. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Products and Services 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/r5lxv6/global
AKESOgen and the VA Million Veteran Program to Collaborate on Genotyping 105,000 Veterans
Business Wire - Wed Mar 05, 9:00AM CST
AKESOgen announced today that it has been awarded a $7.5M contract by the U.S. Department of Veterans Affairs (VA) for genotyping samples from U.S. veterans as part of the Million Veteran Program (MVP). This award covers the genotyping of 105,000 veterans in the first year of a five-year contract.
Global Proteomics Market 2012-2016: One of the Main Drivers in This Market Is the Increasing Demand for Personalized Medicines
M2 - Fri Feb 28, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/dn2hwq/global_proteomics) has announced the addition of the "Global Proteomics Market 2012-2016" report to their offering. The analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp. The other vendors mentioned in the report are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., and Bruker Daltonics Inc. Commenting on the report, an analyst from the Healthcare team said: ''One of the recent trends being witnessed in the Global Proteomics market is the growing popularity of proteomic analysis as compared to genomic analysis. Both genomics and proteomics find application in drug discovery, disease diagnosis, and drug development. Genomics is the study of the genes or DNA of an organism. Proteomics, which was introduced after genomics, has become more popular because it offers more benefits than genomics. For instance, proteomic analysis is faster and more effective in terms of data analysis than genomic analysis. Thus, there is a considerable shift from genomics to proteomics for disease diagnosis and drug development. This trend augers well for the growth of the Global Proteomics market during the forecast period.'' For more information visit http://www.researchandmarkets.com/research/dn...proteomics About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
3 Stocks Under $10 Making Big Moves
at The Street - Wed Feb 26, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Global Life Science and Chemical Instrumentation Market 2012-2016: Market Size and CAGR
M2 - Tue Feb 25, 12:15PM CST
Research and Markets (http://www.researchandmarkets.com/research/25grxg/global_life) has announced the addition of the "Global Life Science and Chemical Instrumentation Market 2012-2016" report to their offering. The analysts forecast the Global Life Science and Chemical Instrumentation market to grow at a CAGR of 8.64 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid technological developments in the Diagnostics industry. The Global Life Science and Chemical Instrumentation market has also been witnessing an increasing number of outsourcing activities. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Roche Holding Ltd., Thermo Fischer Scientific Inc., Life Technologies Corp., and Agilent Technologies Inc. The other vendors mentioned in the report are Danaher Corp., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Affymetrix Inc., GE Healthcare Ltd., Perkin Elmer Inc., Siemens Healthcare, Abbott Laboratories, Hitachi High-technologies Corp., RainDance Technologies Inc., Tecan Group Ltd., Eppendorf AG, Oxford Nanopore Technologies Ltd., and Genia Corp. Commenting on the report, an analyst from Healthcare team said: ''Increasing outsourcing activities is one of the emerging trends in the Global Life Science and Chemical Instrumentation market. Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. This is because outsourcing reduces manufacturing and distribution costs, ensures quality of services, and reduces lead time. In addition, it helps the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. On this front, the Asian and Latin American countries are experiencing high growth. For instance, one of the most preferred locations for outsourcing is Singapore because it is known for its strong intellectual property laws, excellent supply chain, and wide logistics connectivity. Moreover, it is considered a major base for setting up biotechnology and pharmaceutical manufacturing companies because of favorable tax incentives.'' For more information visit http://www.researchandmarkets.com/research/25...lobal_life About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Myriad Genetics Unveils Prolaris Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 1:50PM CST
Shares of Myriad Genetics surged 11.4% at yesterday's market close following the company's recent release of positive data on its Prolaris test.
The Bioinformatics Market to Expand at a CAGR of Around 18.5% during 2013-2017
M2 - Tue Feb 11, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/cnkvh4/global) has announced the addition of the "Global Bioinformatics Market Forecast to 2017" report to their offering. Bioinformatics has become one of the liveliest markets in the present scenario and is at the forefront of biotech revolution. The increasing application of genomics in biotech and pharmaceutical research & development has created a huge commercial market for bioinformatics worldwide. Over the past decade, the bioinformatics market has significantly evolved across the globe on the back of rising genomics industry. In the latest research study, Global Bioinformatics Market Forecast to 2017, analysts identified that the global bioinformatics market reached the mark of around US$ 3.2 Billion in 2012. In future, the bioinformatics market will expand at a CAGR of around 18.5% during 2013-2017 as the declining cost of human genome sequencing and increasing public & private sector investments will give a significant boost to the industry. Our report also covers the key trends and drivers like rising potential of bioinformatics outsourcing industry, cloud computing in bioinformatics, increasing bioinformatics R&D efforts by players etc. In its report, we have studied the bioinformatics market performance by segments, by applications and by regions. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. In 2012, the tools and database market including specialized and generalized databases was the biggest segment of the global bioinformatics industry. In addition, the report analyzes the wide application of bioinformatics in genomics, proteomics and pharmacogenomics. Regional analysis includes the market's categorization into Europe, Asia-pacific and North America, the leading regions in 2012. Further, country level analysis discusses bioinformatics market in major countries like US, Germany, South Korea, UK, Japan etc., to understand their individual market growth and future directions. In addition, the market has witnessed the launches of key bioinformatics products and services in various areas, and we have evaluated these on the basis of the companies and countries, in its report. Companies Mentioned: - 3rd Millennium Inc - Accelrys, Inc. - Affymetrix, Inc. - Biodiscovery, Inc - CLC Bio A/S - Compugen Ltd. - Geneva Bioinformatics (Genebio) SA - Genologics Life Sciences Software, Inc - Kinexus Bioinformatics Corporation - Life Technologies Corporation For more information visit http://www.researchandmarkets.com/research/cnkvh4/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Affymetrix Slips to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 2:30PM CST
On Feb 7, Zacks Investment Research downgraded Affymetrix to a Zacks Rank #3 (Hold).
3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Feb 08, 7:00AM CST
What kind of week do you suppose Peyton Manning, star quarterback of the Denver Broncos, had this week? After the horrible Super Bowl loss to the Seattle Seahawks, it probably wasn't too great for Manning and the rest of the Denver team. ...
Covance Tops Earnings & Revs, Initiates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 12:20PM CST
Covance reported adjusted earnings per share (EPS) of 87 cents in the fourth quarter of 2013.
Affymetrix (AFFX) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 8:37AM CST
Affymetrix (AFFX) Enters Oversold Territory
TrendingWallStreet.com Conducts Research on AFFX, WUBA, PLPL, and SFLY
ACCESSWIRE - Thu Feb 06, 11:18PM CST
Whether it's a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Nasdaq stocks posting largest percentage decreases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Acquisition and Earnings Beat Lift Myriad Shares - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 4:00PM CST
Myriad shares rise following twin announcements made by the company.
Why Affymetrix, Inc. Shares Dropped
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 06, 12:14PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Affymetrix , a life science tools and...
Affymetrix Sees Turnaround Quarter but Earnings Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 8:50AM CST
The turnaround result was caused by increase in revenues and decrease in costs and expenses during the quarter.
Myriad Genetics Inc. (MYGN) Soars: Stock Adds 15.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 8:21AM CST
Myriad Genetics Inc. (MYGN) was a big mover last session, as the company saw its shares rise by over 15% on the day.
Strength Seen in Pain Therapeutics Inc. (PTIE) Stock Surges 24% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 7:44AM CST
Pain Therapeutics Inc. was a big mover last session, as the company saw its shares surge over 21% on the day.
(0)
(0)Affymetrix Inc. (AFFX) Stock Research Links
Scroll down for more posts ▼